Your browser doesn't support javascript.
loading
Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia.
Ottesen, Anett H; Carlson, Cathrine R; Eken, Olav Søvik; Sadredini, Mani; Myhre, Peder L; Shen, Xin; Dalhus, Bjørn; Laver, Derek R; Lunde, Per Kristian; Kurola, Jouni; Lunde, Marianne; Hoff, Jon Erik; Godang, Kristin; Sjaastad, Ivar; Pettilä, Ville; Stridsberg, Mats; Lehnart, Stephan E; Edwards, Andrew G; Lunde, Ida G; Omland, Torbjørn; Stokke, Mathis K; Christensen, Geir; Røsjø, Helge; Louch, William E.
Afiliação
  • Ottesen AH; Division of Medicine, Akershus University Hospital, Lørenskog, Norway (A.H.O., P.L.M., J.E.H., T.O., H.R.).
  • Carlson CR; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Eken OS; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Sadredini M; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Myhre PL; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Shen X; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Dalhus B; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Laver DR; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Lunde PK; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Kurola J; Division of Medicine, Akershus University Hospital, Lørenskog, Norway (A.H.O., P.L.M., J.E.H., T.O., H.R.).
  • Lunde M; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Hoff JE; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Godang K; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Sjaastad I; Department for Microbiology, Clinic for Laboratory Medicine (B.D.), Oslo University Hospital, Norway.
  • Pettilä V; Department for Medical Biochemistry, Institute for Clinical Medicine (B.D.), University of Oslo, Norway.
  • Stridsberg M; School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, New South Wales, Australia (D.R.L.).
  • Lehnart SE; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Edwards AG; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Lunde IG; Division of Intensive Care Medicine, Kuopio University Hospital, Finland (J.K.).
  • Omland T; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
  • Stokke MK; Center for Heart Failure Research (A.H.O., C.R.C., O.S.E., M. Sadredini, P.L.M., X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., T.O., M.K.S., G.C., H.R., W.E.L.), University of Oslo, Norway.
  • Christensen G; Division of Medicine, Akershus University Hospital, Lørenskog, Norway (A.H.O., P.L.M., J.E.H., T.O., H.R.).
  • Røsjø H; Section of Specialized Endocrinology, Department of Endocrinology (K.G.), Oslo University Hospital, Norway.
  • Louch WE; Institute for Experimental Medical Research (A.H.O., C.R.C., O.S.E., M. Sadredini, X.S., P.K.L., M.L., I.S., A.G.E., I.G.L., M.K.S., G.C., W.E.L.), Oslo University Hospital, Norway.
Circ Arrhythm Electrophysiol ; 12(4): e007045, 2019 04.
Article em En | MEDLINE | ID: mdl-30943765
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeos / Taquicardia Ventricular / Secretogranina II / Parada Cardíaca Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeos / Taquicardia Ventricular / Secretogranina II / Parada Cardíaca Idioma: En Ano de publicação: 2019 Tipo de documento: Article